Net profit of Pfizer rose 61.14% to Rs 150.71 crore in the quarter ended June 2024 as against Rs 93.53 crore during the previous quarter ended June 2023. Sales rose 5.93% to Rs 562.86 crore in the quarter ended June 2024 as against Rs 531.36 crore during the previous quarter ended June 2023.
| Particulars | Quarter Ended |
| Jun. 2024 | Jun. 2023 | % Var. |
| Sales | 562.86 | 531.36 | 6 |
| OPM % | 31.53 | 20.84 | - |
| PBDT | 217.22 | 141.30 | 54 |
| PBT | 202.62 | 125.75 | 61 |
| NP | 150.71 | 93.53 | 61 |